Preliminary Evaluation of Two Rapid Diagnostic Test Prototypes for Strongyloides Stercoralis Infe⦠(NCT06368609) | Clinical Trial Compass
UnknownNot Applicable
Preliminary Evaluation of Two Rapid Diagnostic Test Prototypes for Strongyloides Stercoralis Infection
Italy100 participantsStarted 2024-04
Plain-language summary
Single center, no profit experimental study on sera available in the Tropica Biobank.
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Serum from immigrants from S. stercoralis endemic countries (i.e. individuals from Africa, Latin America, South-East Asia and western Pacific regions);
* Serum with a matched result of APC and/or PCR for S. stercoralis (i.e. the latter test/s done in the same day or ±30 days from the collection of the serum) and of serology assays (IFAT and/or ELISA) in use in our laboratory.
Exclusion Criteria:
* Unavailable/insufficient quantity of serum
* Serum from individuals who received treatment with ivermectin in the previous 6 months.